|
Jun 2
|
ASCO25: Johnson & Johnson reports data from Phase I trial of prostate cancer drug
|
|
Jun 2
|
COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?
|
|
May 29
|
HistoSonics’ histotripsy system receives early market access authorisation in UK
|
|
May 29
|
3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row
|
|
May 28
|
Johnson & Johnson (JNJ) Stock Moves -0.54%: What You Should Know
|
|
May 28
|
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
|
|
May 28
|
Boston Scientific ends TAVR sales; J&J shares Monarch robot data
|
|
May 27
|
1 Top Dividend Stock to Buy for a Lifetime of Passive Income
|
|
Apr 17
|
Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025
|
|
Apr 17
|
Here's How You Should Play JNJ Stock After Q1 Earnings Beat
|
|
Apr 17
|
Netflix stock has been nearly unscathed by Trump tariffs. Some think it could be Silicon Valley’s version of Johnson & Johnson
|
|
Apr 17
|
This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row
|
|
Apr 16
|
Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ
|
|
Apr 16
|
J&J’s electrophysiology sales dip amid slow Varipulse start
|
|
Apr 16
|
Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz
|
|
Apr 16
|
Needham upgrades Boston Scientific on easing competition, growth opportunities
|
|
Apr 16
|
Is Johnson & Johnson (JNJ) the Best Dividend Monarch to Invest in Now?
|
|
Apr 16
|
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike
|
|
Apr 16
|
Jim Cramer: Johnson & Johnson (JNJ) Is a “Great American Company with a AAA Balance Sheet”
|
|
Apr 16
|
Johnson & Johnson (JNJ) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid STELARA ...
|